Elucidating the exact pharmacological mechanism of action (MOA) of Normally transpiring compounds is often challenging. Even though Tarselli et al. (60) developed the very first de novo synthetic pathway to conolidine and showcased this naturally taking place compound efficiently suppresses responses to both chemically induced and inflammation-deri